Biblio

Export 3139 results:
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
M. B. Dinkins, Wang, G., and Bieberich, E., “Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.”, J Alzheimers Dis, vol. 60, no. 3, pp. 757-768, 2017.
J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
C. Bussè, Anselmi, P., Pompanin, S., Zorzi, G., Fragiacomo, F., Camporese, G., Di Bernardo, G. Antonio, Semenza, C., Caffarra, P., and Cagnin, A., “Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1009-1015, 2017.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
M. Defrancesco, Marksteiner, J., Kemmler, G., Dal-Bianco, P., Ransmayr, G., Benke, T., Mosbacher, J., Höller, Y., and Schmidt, R., “Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).”, J Alzheimers Dis, vol. 73, no. 1, pp. 125-133, 2020.
M. A. Fernández-Blázquez, Ávila-Villanueva, M., Maestú, F., and Medina, M., “Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
A. Tiiman, Luo, J., Wallin, C., Olsson, L., Lindgren, J., Jarvet, J., Per, R., Sholts, S. B., Rahimipour, S., Abrahams, J. Pieter, Karlström, A. Eriksson, Gräslund, A., and Wärmländer, S. K. T. S., “Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.”, J Alzheimers Dis, vol. 54, no. 3, pp. 971-982, 2016.
F. Carbonell, Zijdenbos, A. P., and Bedell, B. J., “Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 2, pp. 543-557, 2019.
M. Ángel Ara Caballero, Klöppel, S., Dichgans, M., and Ewers, M., “Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.”, J Alzheimers Dis, vol. 55, no. 1, pp. 343-358, 2017.
M. Zanco, Plácido, J., Marinho, V., Ferreira, J. Vinicius, de Oliveira, F., Monteiro-Junior, R., Barca, M., Engedal, K., Laks, J., and Deslandes, A., “Spatial Navigation in the Elderly with Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1683-1694, 2018.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., “Spatial Navigation in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., “Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
G. Liu, Sun, J. - Y., Xu, M., Yang, X. - Y., and Sun, B. - L., “SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1121-1128, 2017.
E. Gómez-Tortosa, Ruggiero, M., Sainz, M. José, Villarejo-Galende, A., Prieto-Jurczynska, C., Pérez, B. Venegas, Ordás, C., Agüero, P., Guerrero-López, R., and Pérez-Pérez, J., “SORL1 Variants in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1275-1281, 2018.
H. Jin, Wang, R., Liu, Z., Jia, Q., Wu, Y., Zhao, Z., Wang, Y., and Zhang, X., “Some Methodological Characteristics of Alzheimer-Associated Urine Neuronal Thread Protein Detected by Enzyme-Linked Immunosorbent Assay.”, J Alzheimers Dis, vol. 63, no. 1, pp. 255-262, 2018.
B. - S. Rauchmann, Sadlon, A., and Perneczky, R., “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., “Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.”, J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
K. N. Hascup and Hascup, E. R., “Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine Receptor.”, J Alzheimers Dis, vol. 53, no. 1, pp. 337-47, 2016.
A. J. Espay, Sturchio, A., Schneider, L. S., and Ezzat, K., “Soluble Amyloid-β Consumption in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1403-1415, 2021.
M. Jin, Shepardson, N., Yang, T., Chen, G., Walsh, D., and Selkoe, D. J., “Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.”, Proc Natl Acad Sci U S A, vol. 108, no. 14, pp. 5819-24, 2011.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
E. Abdin, Subramaniam, M., Achilla, E., Chong, S. Ann, Vaingankar, J. Ajit, Picco, L., Sambasivam, R., Pang, S., Chua, B. Yiang, Ng, L. Ling, Chua, H. Choon, Heng, D., Prince, M., and McCrone, P., “The Societal Cost of Dementia in Singapore: Results from the WiSE Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 439-49, 2016.
J. Hirt, Ballhausen, N., Hering, A., Kliegel, M., Beer, T., and Meyer, G., “Social Robot Interventions for People with Dementia: A Systematic Review on Effects and Quality of Reporting.”, J Alzheimers Dis, vol. 79, no. 2, pp. 773-792, 2021.

Pages